Medical/Pharmaceuticals
Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc.
Marks the First Entry of Biokangtai's 13-valent Pneumococcal Vaccine into Southeast Asian Market SHENZHEN, China, Aug. 31, 2022 /PRNewswire/ -- On August 30, Beijing Minhai Biotechnology Co., Ltd. held a signing ceremony with Phil. Pharmawealth, Inc. for their cooperation in jointly promoting th...
2022-08-31 17:05
2760
TikoMed's ILB® mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including ALS
VIKEN, Sweden, Aug. 31, 2022 /PRNewswire/ -- TikoMed, a biopharmaceutical company focused on harnessing the medical potential of the body's ability to self-repair and regenerate, today announced the publication in Frontiers in Phamacology of peer-reviewed research supporting the unique broad spec...
2022-08-31 15:29
1924
NIAID/NIH recognizes the potency of UB-421 against multi-drug resistant HIV and receives the FDA approval to conduct a phase 2 clinical trial with UB-421
TAIPEI, Aug. 31, 2022 /PRNewswire/ -- United BioPharma (UBP) announced today that the U.S. Food and Drug Administration (FDA) has approved a phase 2 clinical trial IND submitted by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of NIH. The purpose of this study is to asses...
2022-08-31 12:24
2574
NuraLogix researchers announce AI models that can predict Blood Biomarker Risk
TORONTO, Aug. 31, 2022 /PRNewswire/ -- Researchers at NuraLogix, a global leader in HealthTech AI, announced today that they have developed AI models that can predict a person's risk of HbA1C levels and Fasting Blood Glucose levels being above a significant clinical threshold for pre-diabetes....
2022-08-31 11:32
2711
GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance
YONGIN, South Korea and AUSTIN, Texas, Aug. 30 2022 /PRNewswire/ -- GC Biopharma (006280.KS) and Speragen today announced that a joint Externally Led - Patient-Focused Drug Development (EL-PFDD) meeting hosted by SSADH Association and attended by the U.S. FDA and other stakeholders was held to a...
2022-08-31 08:33
2851
Antengene Announces Interim 2022 Financial Results and Provides Corporate Update
- Revenue of RMB 53.96 million mainly driven by the commercial launch of XPOVIO® (selinexor) in Mainland China onMay 13, 2022 - Adjusted loss reduced to RMB 126 million for the first six months of 2022 fromRMB 210 million in the same period last year - Cash and bank balances of RMB 2.151 billion...
2022-08-31 08:29
3719
Biomedical industry bears fruit again in National Nanning Economic & Technological Development Area
NANNING, China, Aug. 31, 2022 /PRNewswire/ -- Recently, the lung CT image-aided diagnosis software developed by Guangxi Yizhun Intelligent Technology Co., Ltd. ("Yizhun") in National Nanning Economic & Technological Development Area ("Area") has been granted the registration certificate of class ...
2022-08-31 00:32
3142
ZEISS Integrated Workflow Solutions are Creating the Digital Transformation in Healthcare
The fully connected environment, digital technologies and artificial intelligence tools enable optimization of patient care. JENA, Germany and DUBLIN, Aug. 30, 2022 /PRNewswire/ -- ZEISS Medical Technology continues to build on its leadership in digital solutions by exploring new ways to advanc...
2022-08-30 22:00
3349
LifeTech Scientific Corporation (1302.HK) Announces 2022 Interim Results
* Revenue increased by 20.4%, net profit attributable to owners of the Company increased by 34.4% after excluding certain non-recurring items SHENZHEN, China, Aug. 30, 2022 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "Lifetech"), a leading company specialized in minimally ...
2022-08-30 21:45
5593
Fosun Pharma Announces 2022 Interim Results
Stable Revenue Growth and Recurring Income, Elevating the Revenue Contribution of New Products, and Accelerating International Layout Highlights: * Revenue for the first half of 2022 amounted to RMB21,340 million, an increase of 25.88% YOY; * Net profit (after extraordinary gain or loss) att...
2022-08-30 20:28
4589
Optina Diagnostics Earns Frost & Sullivan's 2022 North American Technology Innovation Leadership Award for Leveraging Innovative Eye Imagery and Artificial Intelligence for Chronic Diseases Detection including Alzheimer's
Optina Diagnostics' solutions enable specialists and primary care physicians to diagnose chronic diseases including Alzheimer's with reliable and precise retinal scans. SAN ANTONIO, Aug. 30, 2022 /PRNewswire/ -- Based on its recent analysis of the North American Hyperspectral Retinal Imaging Ind...
2022-08-30 20:00
2895
VitalLife Achieves GHA's Certification for Excellence in Medical Travel Patient Experience
PALM BEACH GARDENS, Fla., Aug. 30, 2022 /PRNewswire/ -- VitalLife Scientific
Wellness Center in Bangkok, Thailand has achieved Certification for Excellence
in Medical Travel Patient Experience byGlobal Healthcare Accreditation (GHA).
2022-08-30 18:00
3603
I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Six Months Ended June 30, 2022
* Seven key clinical milestones achieved year-to-date, including positive data readouts for lemzoparlimab, uliledlimab, and TJ-CD4B * Lemzoparlimab is on track for Phase 3 study for 1L MDS * Amendment to the global partnership with AbbVie for certain new CD47 antibodies currently in developm...
2022-08-30 18:00
3231
'Medlab Asia & Asia Health 2022' to Promote Thailand as a Medical Hub of ASEAN by Collaborating with Department of Health Service Support and Medical Industry
BANGKOK, Aug. 30, 2022 /PRNewswire/ -- 'Medlab Asia & Asia Health 2022' is the leading medical event in the ASEAN region which is all set to run in Thailand for the first time, co-hosted by IMPACT Exhibition Management and Informa Markets, and supported by Department of Health Service Support, Mi...
2022-08-30 15:35
3123
Baxter Hosts 2022 Digital Surgery Summit: Reimagining Connected Surgery
Inspiring surgical innovation for patient care based on connectivity
SINGAPORE, Aug. 30, 2022 /PRNewswire/ -- Baxter International Inc.
2022-08-30 10:10
3644
New report highlights the technology key to fighting future pandemics
MELBOURNE, Australia, Aug. 30, 2022 /PRNewswire/ -- CSIRO, Australia's national science agency, has outlined the science and technology that can help improve resilience to future pandemics, reduce their economic impact and protect communities. The Strengthening Australia's Pandemic Preparedness ...
2022-08-30 04:00
4848
Kintor Announces 2022 Interim Results and Recent Business Update
SUZHOU, China, Aug. 29, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma" or "the Company", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced its 2022 interim results and released an update on i...
2022-08-30 00:19
4405
Gracell Biotechnologies to Participate in Four Upcoming Investor Conferences
SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Aug. 29, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment o...
2022-08-29 21:00
3399
NEXT-GENERATION EGFR TKI H002 FROM REDCLOUD BIO COMPLETES FIRST DOSE IN NON-SMALL CELL LUNG CANCER
* H002 is a precision therapeutic candidate for the treatment of NSCLC, with broad spectrum and high selectivity against multiple EGFR mutations including those with EGFR C797S mutation. * RedCloud Bio has initiated H002 Phase I/IIa clinical studies in both China and US. SHANGHAI, Aug. 29, 20...
2022-08-29 19:30
2867
Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma
Data showed an excellent safety profile with no adverse events among the five subjects treated. Company continues to explore doses in the ongoing Phase II dose escalation study GAITHERSBURG, Md and SUZHOU, China, Aug. 29, 2022 /PRNewswire/ -- Sirnaomics Ltd.(the "Company" or "Sirnaomics", stock ...
2022-08-29 15:59
4241
Week's Top Stories
Most Reposted
Visa and Marina Bay Precinct Partners - Marina Bay Sands, UOB and Singapore Tourism Board - Present 'A Moment to Savour', Bringing International Restaurant Collaborations to Singapore
[Picked up by 310 media titles]
2026-10-27 13:40
Hong Leong Bank Strengthens Cross-Border Payment Connectivity through Partnership with UnionPay International
[Picked up by 294 media titles]
2026-10-28 12:12
Agoda becomes first travel platform regionally to seamlessly connect with Meta's Muse
[Picked up by 294 media titles]
2026-10-28 09:00
OneQode Signs 14 MW AI Capacity Agreement with AdaniConneX, with a Path to 114 MW
[Picked up by 277 media titles]
2026-10-28 09:00
Pepperstone and Aston Martin Aramco extend and expand partnership with Fernando Alonso appointed Global Ambassador from 2027.
[Picked up by 276 media titles]
2026-10-29 13:01
Most Read
SwitchBot Launches AI Art Frame 2 with Full-Color E Ink and Personalized Art
2026-10-27 21:00
43748
Cuttable Unveils Next-Generation AI Advertising Platform as U.S. Expansion Accelerates
2026-10-24 00:00
33975
The Future of AI 3D Character Workflows: Reallusion CC 5.2 Turns Meshes into Living Characters
2026-10-29 20:03
19123
ROKAE delivers its 10,000th humanoid force-controlled arm
2026-10-27 00:00
17169
